🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Neuromyelitis Optica Spectrum Disorder Attack

Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study NCT07410039Phase 41 site📍 Beijing Chinese PLA General Hospital · Tests: Eculizumab+IVMP, IVIG+IVMP, IVMP Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder NCT07738952Phase 1, Phase 21 site📍 Fukuoka Kyushu University · Tests: Sivelestat sodium hydrate A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD NCT07762872n/a1 site📍 Beijing Junwei Hao, MD · Tests: Satralizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy